Labelling of Interleukin-2 (IL-2) with 123-Iodine with Retention of Its Capacity to Bind to Activated Lymphocytes

Experimental and Clinical Endocrinology and Diabetes - Tập 89 Số 03 - Trang 301-306
Alberto Signore1, Peter Beverley1, A.Ü. Parman2, M Negri3, Paolo Pozzilli2
1ICRF, HTIG, Faculty of Clinical Sciences, University College London
2Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, London, UK
3Cattedra Endocrinologia I, Clinica Medica II, University of Rome “La Sapienza”/ Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo